Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas

Clinical trial NCT05216120 · WITHDRAWN

Trial details

NCT number: NCT05216120
Sponsor: HonorHealth Research Institute
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreas Cancer

Start date: 2022-06-14
Primary completion: 2024-08-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.